Leading board-certified sleep medicine physicians and board-certified sleep dentists on why they chose Alesis OSA1 — and what they are seeing in their patients.
An AHI of 22.4 places a patient in the moderate obstructive sleep apnea range. After completing six 12-minute sessions over three weeks, Dr. Fisher's first patient recorded an AHI of 3.1 on the post-treatment sleep study.
The clinical threshold for OSA is an AHI ≥ 5. This patient is below that — without CPAP, without surgery, and without ongoing device dependency.
Quadruple board-certified physicians in internal medicine, pulmonology, critical care, and sleep medicine — among the most credentialed practitioners in sleep medicine — on what OSA1 means for patients who cannot tolerate PAP therapy.
"Alesis OSA1 offers a novel approach that goes beyond simply managing symptoms. Alesis helps resolve one of the primary contributors to airway collapse by reducing fat. This innovative therapy may provide hope for individuals who have struggled with traditional PAP treatments and need an expanded treatment that addresses the root of their sleep disorder."
Dr. Sulieman is the founder of The Sleep Lab Hawaii and the first Alesis OSA1 provider in the state. A Fellow of the American Academy of Sleep Medicine with over 40 years of clinical experience, he brings one of the most distinguished careers in sleep medicine to the Alesis Apnea Network.
"CPAP is a life-saving technology for many sleep apnea patients, but a significant number of patients do not tolerate wearing a mask and hose every night. For those patients, Alesis OSA1 offers a non-surgical treatment using a special type of non-laser medical light to shrink fat deposits that interfere with sleep. In clinical trials, 80% of patients achieved improvement in sleep apnea of more than 50%, with some patients seeing an 85% improvement. We are proud to have been selected to introduce this transformative approach to better breathing and sleep."
Dr. Surdulescu is quadruple board-certified and leads Lake Norman Pulmonary & Sleep in Mooresville, North Carolina — a regional center of excellence for sleep medicine serving the Lake Norman community for decades. Ten patients came forward with their credit cards and signed up at his OSA1 launch. At one point, they were chanting as a group, "No Mo Hose."
"South Florida has one of the most diverse patient populations in the country, and sleep apnea does not discriminate. It affects people of every background, every age, and every body type — and far too many of them have been told that CPAP is their only option. I joined the Alesis Apnea Network because the OSA1 gives my patients a real alternative backed by clinical evidence and a guarantee. That combination is rare in medicine, and my patients deserve it."
Dr. Chaudhry brings a critically important clinical perspective: upper airway inflammation driven by allergic rhinitis is a well-established contributor to obstructive sleep apnea, and her expertise bridges the allergy–sleep medicine interface in a way few practitioners can. Trained at Harvard Medical School and Columbia University Vagelos College of Physicians and Surgeons.
Diplomates of the American Board of Dental Sleep Medicine and the American Sleep and Breathing Academy — clinicians who have dedicated their practices to patients for whom traditional PAP therapy has failed.
"I see patients every day who are facing genuinely difficult decisions. They have been told that CPAP is their best option, they have tried sincerely, and they cannot make it work. For years, the alternatives available to them were limited — oral appliances, positional therapy, or major surgery. Alesis OSA1 changes that conversation entirely. For the right patient, it offers a clinically validated, non-surgical treatment that targets the physical source of the obstruction. I am proud to be the first provider in the Seattle area to offer this technology, and deeply committed to helping our patients achieve real, lasting improvement in their sleep and their health."
Eleven patients signed up before Dr. Fisher's OSA1 launch.
"Millions of Americans have been diagnosed with sleep apnea, prescribed a CPAP, and then quietly stopped using it — accepting the risk rather than the machine. Oral appliances provide a healthy alternative. We must consider the multiple factors that contribute to the conditions. Weight loss has been shown to contribute significantly to reduction or elimination of OSA. The Alesis OSA1 finally gives those patients another real alternative. That is a significant moment in sleep medicine."
Dr. Lipskis holds four board certifications and leads the TMJ & Sleep Therapy Centre of Chicago. After two decades navigating her own TMJ and sleep-disordered breathing symptoms, she trained under leading experts in the field and dedicated her practice exclusively to dental sleep medicine and TMD treatment using a non-invasive, holistic, multidisciplinary approach.
"Patients in the Upper Peninsula have the same medical needs as patients anywhere in the country, but they have historically had far fewer options. Joining the Alesis Apnea Network means my patients who have struggled with CPAP now have a credentialed, clinically supported alternative right here at home. That is something I am genuinely excited to be a part of."
Dr. Wiggins earned her DDS from the University of Michigan School of Dentistry, graduating at the top of her class, and has served the Marquette community for more than 30 years. She holds four diplomate designations and practices with a whole-patient, holistic philosophy.